| CLCN2 |
|---|
|
| Identifiers |
|---|
| Aliases | CLCN2, CIC-2, CLC2, ECA2, ECA3, EGI11, EGI3, EGMA, EJM6, EJM8, LKPAT, clC-2, chloride voltage-gated channel 2, HALD2 |
|---|
| External IDs | OMIM: 600570; MGI: 105061; HomoloGene: 3213; GeneCards: CLCN2; OMA:CLCN2 - orthologs |
|---|
|
| Gene location (Mouse) |
|---|
| | Chr. | Chromosome 16 (mouse) |
|---|
| | Band | 16 A3- B1|16 12.5 cM | Start | 20,521,714 bp |
|---|
| End | 20,536,496 bp |
|---|
|
|
|
|
| Wikidata |
|
Chloride channel protein 2 is a protein that in humans is encoded by the CLCN2 gene. Mutations of this gene have been found to cause leukoencephalopathy and Idiopathic generalised epilepsy (OMIM: 600699), although the latter claim has been disputed.
A gain of function mutation in the CLCN2 gene was found to cause primary aldosteronism, a form of arterial hypertension due to excessive production of aldosterone by the neuroendocrine cells of the zona glomerulosa of the adrenal gland. The mutation was found to cause a chloride leak in these cells and increased the expression of aldosterone synthase.
CLCN2 contains a transmembrane region that is involved in chloride ion transport as well two intracellular copies of the CBS domain.